Martin Hasselblatt Selected Research

Rhabdoid Tumor Predisposition Syndrome 1

1/2021

Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Hasselblatt Research Topics

Disease

55	Neoplasms (Cancer) 10/2022 - 10/2003
15	Glioma (Gliomas) 01/2022 - 11/2008
14	Rhabdoid Tumor (Rhabdoid Tumors) 12/2021 - 10/2006
9	Choroid Plexus Neoplasms (Choroid Plexus Tumor) 05/2020 - 01/2006
9	Medulloblastoma 01/2020 - 07/2009
8	Choroid Plexus Papilloma 12/2021 - 01/2006
8	Brain Neoplasms (Brain Tumor) 01/2019 - 01/2006
7	Typical Teratoid Rhabdoid Tumor 01/2022 - 06/2011
7	Primitive Neuroectodermal Tumors (PNET) 02/2016 - 11/2010
6	Ependymoma 01/2021 - 10/2003
6	Glioblastoma (Glioblastoma Multiforme) 01/2017 - 11/2008
5	Choroid Plexus Carcinoma 05/2020 - 01/2006
4	Carcinogenesis 01/2020 - 12/2012
4	Astrocytoma (Pilocytic Astrocytoma) 12/2018 - 08/2013
4	Hypoxia (Hypoxemia) 01/2013 - 07/2002
4	Carcinoma (Carcinomatosis) 09/2012 - 01/2006
3	Meningioma (Meningiomas) 10/2016 - 01/2013
3	Stroke (Strokes) 01/2007 - 08/2002
2	Disease Progression 12/2021 - 10/2006
2	Pinealoma (Pineoblastoma) 01/2020 - 09/2012
2	Small Cell Carcinoma 11/2016 - 04/2015
2	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2016 - 12/2009
2	Pathologic Complete Response 09/2014 - 12/2009
2	Neuroectodermal Tumors (Neuroectodermal Tumor) 08/2013 - 12/2009
2	Neoplasm Metastasis (Metastasis) 12/2009 - 01/2006
2	Ischemic Stroke 01/2007 - 08/2002
2	Brain Ischemia (Cerebral Ischemia) 01/2007 - 08/2005
2	Infarction (Infarctions) 01/2007 - 08/2005
2	Muscular Dystrophies (Muscular Dystrophy) 09/2006 - 06/2006
2	Ischemia 08/2005 - 07/2002
1	Neuroblastoma 10/2022
1	Li-Fraumeni Syndrome 01/2022
1	Central Nervous System Neoplasms 01/2022
1	Chordoma 12/2021
1	Hematologic Neoplasms (Hematological Malignancy) 12/2021
1	Residual Neoplasm 01/2021
1	Insulinoma 01/2021
1	Rhabdoid Tumor Predisposition Syndrome 1 01/2021
1	Turcot syndrome 01/2021
1	Paraganglioma (Paragangliomas) 12/2020

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2006
10	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2006
8	RNA (Ribonucleic Acid)IBA 10/2022 - 08/2012
8	Biological ProductsIBA 12/2021 - 01/2009
6	Histones (Histone)IBA 01/2019 - 07/2009
4	NucleotidesIBA 01/2021 - 01/2018
4	MicroRNAs (MicroRNA)IBA 01/2020 - 11/2010
4	Temozolomide (Temodar)FDA LinkGeneric 01/2017 - 11/2008
4	ParaffinIBA 12/2014 - 10/2009
4	Formaldehyde (Formol)FDA Link 09/2014 - 10/2009
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2011 - 03/2008
3	Pharmaceutical PreparationsIBA 12/2021 - 08/2002
3	Keratins (Keratin)IBA 12/2020 - 10/2008
3	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 05/2020 - 12/2009
3	cytidylyl-(3'-5')-cytidine (CpC)IBA 05/2020 - 12/2009
3	Messenger RNA (mRNA)IBA 01/2020 - 06/2011
3	ChromatinIBA 01/2019 - 03/2016
3	hydrogen sulfite (bisulfite)IBA 03/2016 - 01/2009
3	LigandsIBA 01/2016 - 08/2005
3	Tyrosine Kinase InhibitorsIBA 01/2013 - 11/2010
3	Mucin-1 (CA 15-3 Antigen)IBA 12/2009 - 10/2003
3	Erythropoietin FDA Link 11/2008 - 08/2002
2	AntigensIBA 10/2022 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 06/2011
2	Sucrose (Saccharose)IBA 01/2020 - 11/2016
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2019 - 12/2009
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2010
2	AcidsIBA 01/2019 - 03/2016
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2016 - 01/2016
2	AntibodiesIBA 07/2016 - 01/2006
2	Tyrosine (L-Tyrosine)FDA Link 03/2016 - 11/2010
2	Phosphotransferases (Kinase)IBA 01/2016 - 11/2010
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2013 - 04/2006
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2013 - 01/2013
2	Adenosine Triphosphatases (ATPase)IBA 06/2011 - 02/2010
2	Nonsense Codon (Nonsense Mutation)IBA 06/2011 - 02/2010
2	SynaptophysinIBA 11/2009 - 10/2006
2	Platelet-Derived Growth FactorIBA 10/2009 - 03/2008
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2007 - 08/2005
2	Prealbumin (Transthyretin)IBA 10/2006 - 01/2006
2	Nitric Oxide Synthase (NO Synthase)IBA 09/2006 - 06/2006
1	GlypicansIBA 10/2022
1	Chimeric Antigen ReceptorsIBA 10/2022
1	oncofetal antigensIBA 10/2022
1	CytosineIBA 03/2022
1	Brachyury protein (Brachyury)IBA 12/2021
1	NivolumabIBA 12/2021
1	Decitabine FDA Link 12/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	DNA Transposable Elements (Element, IS)IBA 01/2021
1	SMARCB1 ProteinIBA 01/2021
1	selinexorIBA 01/2021
1	Keratin-18 (Keratin 18)IBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020

Therapy/Procedure

15	Therapeutics 10/2022 - 08/2002
7	Drug Therapy (Chemotherapy) 01/2021 - 11/2008
3	Radiotherapy 01/2020 - 10/2006
3	Ligation 01/2018 - 10/2009
2	Lasers (Laser) 06/2011 - 03/2009